Concepedia

Makoto Shiragami

MS

6

Publications

133

Citations

6

H-Index

2000

Active since

Affiliations

GlaxoSmithKline (Belgium)(Current)

Teikyo Heisei University

Nihon University

Ministry of Health Labour and Welfare

Aichi Medical University

Makoto Shiragami is an author at GlaxoSmithKline (Belgium) specializing in drug discovery, substance abuse, and pharmacoepidemiology.

Top concepts

Publications per year

2000–2019

6

Publications

6

Contribution of antimicrobial stewardship programs to reduction of antimicrobial therapy costs in community hospital with 429 Beds --before-after comparative two-year trial in Japan

Tetsuya Fukuda, Hidemi Watanabe, Saeko Ido et al. · Journal of Pharmaceutical Policy and Practice · 2014 · 39 citations · Full text

Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children

Makoto Shiragami, Akiko Mizukami, Oscar Leeuwenkamp et al. · Infectious Diseases and Therapy · 2014 · 33 citations · Full text

The Potential Public Health Impact of Herpes Zoster Vaccination of People Aged ≥ 50 Years in Japan: Results of a Markov Model Analysis

Daisuke Watanabe, Akiko Mizukami, Katsiaryna Holl et al. · Dermatology and Therapy · 2018 · 21 citations · Full text

Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older

Makoto Shiragami, Akiko Mizukami, Toshihiko Kaise et al. · Dermatology and Therapy · 2019 · 16 citations · Full text

Development of Orphan Drugs in Japan: Effects of a Support System for Development of Orphan Drugs in Japan

Makoto Shiragami, Kiyohito Nakai · Drug Information Journal · 2000 · 13 citations

, , +10

Rows per page

1–5 of 6